62856-350 : Lusedra 35 mg/ml Intravenous Injection
NDC: | 62856-350 |
Labeler: | Eisai, Inc |
Product Type: | Human Prescription Drug |
Drug Name: | Lusedra |
Dosage Form: | Intravenous Injection |
Application #: | NDA022244 |
Rev. Date: | |
CSA Schedule: | CIV (US) [1] |
[1] Schedule IV Controlled Substance: Low potential for abuse relative to substances in Schedule III. Examples include Alprazolam (Xanax), Diazepam (Valium), Carisoprodol (Soma), Clonazepam (Klonopin), Lorazepam (Ativan), Clorazepate (Tranxene), Midazolam (Versed), Temazepam (Restoril), and Triazolam (Halcion).. More Details: US Dept of Justice Controlled Substance Schedules.
NDC Package Codes:
- 62856-350-08: 8 VIAL IN 1 TRAY (62856‑350‑08) > 30 ML IN 1 VIAL
- 62856-350-58: 8 VIAL IN 1 TRAY (62856‑350‑58) > 30 ML IN 1 VIAL
Active Ingredients:
- Fospropofol Disodium
Dosage Strength:
- 35 mg/mL
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 62856-290Next: 62856-389 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.